Agendia Announces Publication in JNCI Cancer Spectrum Demonstrating that MammaPrintยฎ Predicts Chemotherapy Benefit in HR+HER2- Early Breast Cancer Using Real-World Evidence from the FLEX Study
IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS โ August 12, Read More